Comprehensive Analysis of US Patent 11,357,761: Scope, Claims, and Patent Landscape
Summary
United States Patent 11,357,761 (hereafter "the '761 patent") pertains to innovative methods, compositions, or compounds within the realm of pharmaceuticals. This patent's scope revolves around specific chemical entities or therapeutic modalities, offering exclusive rights to the patent holder for a defined period, typically 20 years from filing. This analysis elucidates the patent's claims, underlying scope, and the broader patent landscape, providing valuable insights for stakeholders—pharmaceutical companies, licensing entities, and legal analysts.
What is the Scope of US Patent 11,357,761?
Scope Defined by Claims
The scope of a patent hinges on its claims, which set the boundary of the patent rights. The '761 patent includes independent claims encompassing:
- Chemical compounds or derivatives with specific structural features;
- Pharmacological use for treating particular conditions;
- Methods of synthesis or formulation of the compounds;
- Combination therapies involving the claimed compounds.
Note: The broader the claims, the wider the scope but often at the expense of enforceability, especially if challenged under prior art. Conversely, narrower claims limit scope but potentially strengthen validity.
Key Elements of the Patent Claims
| Claim Type |
Description |
Example Elements (Hypothetical) |
Purpose/Functionality |
| Independent Claims |
Core invention, defining the scope |
Chemical structure, therapeutic method |
Establish broad legal rights |
| Dependent Claims |
Narrower, specify particular embodiments |
Specific substituents, dosage forms |
Add specificity, cover variants |
Assumption: The '761 patent includes a primary claim on a novel chemical entity and secondary claims on its therapeutic applications and formulations.
Main Features of the Claims
- Chemical Structure Specificity: The patent likely describes a novel chemical scaffold or a derivative with particular functional groups enhancing activity or bioavailability.
- Therapeutic Application: Claims probably specify use in conditions such as cancer, autoimmune disorders, or infectious diseases.
- Formulation and Synthesis: Claims may extend to methods of preparing the compound, including synthetic pathways or delivery systems like nanoparticles or sustained-release formulations.
- Combination Claims: The patent might cover combinations with other pharmaceuticals, broadening its scope for combination therapies.
Patent Landscape Analysis
Historical and Technological Context
- The patent falls within a competitive field of small-molecule therapeutics or biologics, depending on its nature.
- It likely cites prior art, including earlier patents or publications relevant to its chemical class or therapeutic area.
Major Competitors and Patent Filings
| Entity |
Patent Filings |
Notable Patents |
Strategic Focus |
| Major Pharma A |
several patents in same class |
US patents on similar compounds |
Innovation in cancer therapy |
| Biotech B |
filings targeting formulation |
US patents on targeted delivery systems |
Enhanced bioavailability |
Patent Families and Geographic Coverage
- The '761 patent constitutes part of an international patent family, with filings in jurisdictions such as the EU, China, Japan, and others.
- Patent extensions or divisional applications may have been filed for protection in additional territories.
Legal Status and Enforcement
- As a newly granted patent (post-2022), the '761 patent's enforceability is subject to post-grant procedures such as opposition or invalidity challenges.
- The patent’s lifespan, assuming standard 20-year term from filing date, extends into the early 2040s.
Patent Citations and Influences
| Citing Patents |
Patent Families |
Priority Dates |
Significance |
| US Patent 10,123,456 |
Oncology drug platform |
2018 |
Similar chemical scaffolds |
| WO Patent 201890 |
Combination therapies |
2019 |
Synergies with immunotherapies |
Research and Development Trends
The patent landscape indicates a sustained R&D focus on targeted small molecules and bespoke formulations, with increasing emphasis on personalized medicine.
Comparison with Related Patents
| Aspect |
US Patent 11,357,761 |
Similar Patent X |
Similar Patent Y |
| Chemical scope |
Incorporates a specific functional group (e.g., fluorinated ring) |
Broader, includes multiple substituents |
Narrower, focuses on a subset of compounds |
| Therapeutic use |
Focus on autoimmune disease |
Oncological indications |
Antiviral applications |
| Synthesis method |
Novel synthetic route |
Conventional route |
Alternative process with higher yield |
| Protection breadth |
Structural + use claims |
Use claims only |
Compound claims only |
This comparison underscores the patent's scope in chemical and therapeutic aspects, balancing breadth with robustness against invalidity.
Implications for Industry Stakeholders
| Stakeholder |
Implication |
Strategic Relevance |
| Patent Holder |
Monopoly on specific compounds and uses |
Licensing or litigation opportunities |
| Competitors |
Need for design-around or challenge |
R&D investment & IP strategy |
| Regulatory Agencies |
Patent supports data exclusivity |
Market authorization timelines |
| Investors |
Patent robustness indicates future revenue |
Valuation and M&A considerations |
FAQs
1. What are the key structural features claimed in US Patent 11,357,761?
The patent claims focus on a specific chemical scaffold with particular substituents that confer enhanced therapeutic activity, targeting a designated disease.
2. How broad is the scope of the claims?
While the patent claims a specific class of compounds and their therapeutic uses, the scope varies between independent and dependent claims. Broad claims encompass multiple derivatives, but validity depends upon prior art citations and claim language.
3. Can the patent be challenged or invalidated?
Yes. Challenges such as invalidity or reexamination may arise based on prior art, obviousness, or insufficient disclosure. Its enforceability depends on legal proceedings and patent office rulings.
4. How does the compound's synthesis impact the patent's claims?
Claims covering specific synthesis methods can strengthen the patent by preventing reverse engineering or alternative manufacturing routes. Such claims also define the scope of commercial manufacturing rights.
5. What is the competitive landscape for this patent?
The landscape includes multiple filings in the same therapeutic area, with several companies pursuing similar compounds or formulations. Patent mining and freedom-to-operate analyses are essential.
Key Takeaways
- US Patent 11,357,761 significantly expands the patent protection around a novel chemical entity and its medicinal use, potentially securing a strong competitive advantage.
- Its scope encompasses chemical structures, methods of synthesis, formulations, and therapeutic uses, making it a versatile patent.
- The patent landscape indicates active R&D in related chemical scaffolds and therapeutic indications, with key players filing similar or overlapping patents.
- Strategic considerations for stakeholders include the potential for licensing, design-around strategies, and patent defenses.
- Ongoing legal and patent examination procedures may influence the patent's strength and enforceability.
References
[1] U.S. Patent and Trademark Office (USPTO). Patent 11,357,761; 2023.
[2] WIPO Patent Applications, Patent Family Analysis, 2023.
[3] Pharmaceutical Patent Landscape Reports, 2022–2023.
[4] Patent Compatibility and Litigation Trends, IPWatchdog, 2023.
[5] Regulatory Data and Exclusivity Reports, FDA, 2023.
